Literature DB >> 15337327

Determinants of persistence of major depressive episodes in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).

Jan Spijker1, Ron de Graaf, Rob V Bijl, Aartjan T F Beekman, Johan Ormel, Willem A Nolen.   

Abstract

BACKGROUND: Data on determinants of persistence of major depressive episodes (MDE) are inconsistent due to methodological shortcomings of the studies involved. AIMS: To examine determinants of persistence of MDE in subjects from the general population (N=250) with new episodes of DSM-III-R major depression.
METHOD: The Netherlands Mental Health Survey and Incidence Study is a prospective epidemiologic survey in the adult population (N=7076), using the Composite International Diagnostic Interview (CIDI). A broad range of potential determinants was assessed.
RESULTS: Determinants of persistence were severity of the index episode, longer duration of previous episodes, (chronic) physical illness and lack of social support. A recurrent episode predicted shorter duration. LIMITATIONS: Follow-up was only 2 years and duration of episode was retrospectively assessed.
CONCLUSIONS: Just as in clinical populations, illness-related factors seem to be the strongest predictors of persistence of MDE. A thorough assessment of each depressed patient on the predictors of persistence is advisable.

Entities:  

Mesh:

Year:  2004        PMID: 15337327     DOI: 10.1016/j.jad.2003.08.005

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  41 in total

1.  The Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2): design and methods.

Authors:  Ron de Graaf; Margreet Ten Have; Saskia van Dorsselaer
Journal:  Int J Methods Psychiatr Res       Date:  2010-09       Impact factor: 4.035

2.  [Over-diagnosis and over-treatment of major depressive disorder in primary care. An increasing phenomenon].

Authors:  Jaime Adán-Manes; José Luis Ayuso-Mateos
Journal:  Aten Primaria       Date:  2009-11-06       Impact factor: 1.137

3.  Bouncing back: remission from depression in a 12-year panel study of a representative Canadian community sample.

Authors:  Esme Fuller-Thomson; Marla Battiston; Tahany M Gadalla; Sarah Brennenstuhl
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-01-09       Impact factor: 4.328

4.  Trajectories of major depression in middle-aged and older adults: A population-based study.

Authors:  Xiaoling Xiang; Jianjia Cheng
Journal:  Int J Geriatr Psychiatry       Date:  2019-06-25       Impact factor: 3.485

5.  Alcohol Use Disorder and the Persistence/Recurrence of Major Depression: Le trouble de l'usage de l'alcool et la persistance/récurrence de la dépression majeure.

Authors:  Vivian N Onaemo; Timothy O Fawehinmi; Carl D'Arcy
Journal:  Can J Psychiatry       Date:  2020-05-04       Impact factor: 4.356

6.  Bipolar spectrum in major depressive disorders.

Authors:  J Angst; K R Merikangas; L Cui; A Van Meter; V Ajdacic-Gross; W Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-07-21       Impact factor: 5.270

7.  Population-based study of first onset and chronicity in major depressive disorder.

Authors:  William W Eaton; Huibo Shao; Gerald Nestadt; Hochang Benjamin Lee; Ben Hochang Lee; O Joseph Bienvenu; Peter Zandi
Journal:  Arch Gen Psychiatry       Date:  2008-05

8.  Neural activity and diurnal variation of cortisol: evidence from brain electrical tomography analysis and relevance to anhedonia.

Authors:  Katherine M Putnam; Diego A Pizzagalli; Diane C Gooding; Ned H Kalin; Richard J Davidson
Journal:  Psychophysiology       Date:  2008-09-24       Impact factor: 4.016

9.  A tale of two comorbidities: Understanding the neurobiology of depression and pain.

Authors:  Meera Narasimhan; Nioaka Campbell
Journal:  Indian J Psychiatry       Date:  2010-04       Impact factor: 1.759

10.  Patterns of depressive disorders across 13 years and their determinants among midlife women: SWAN mental health study.

Authors:  Joyce T Bromberger; Howard M Kravitz; Ada Youk; Laura L Schott; Hadine Joffe
Journal:  J Affect Disord       Date:  2016-07-05       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.